Ipamorelin / CJC-1295 (No DAC)
The classic growth-hormone stack in one vial.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Ipamorelin / CJC-1295 (No DAC)
This blend pairs Ipamorelin, a selective growth-hormone secretagogue, with CJC-1295 (No DAC), a short-acting GHRH analogue. The two act on different receptors to amplify a clean, pulsatile release of growth hormone without significantly raising cortisol or prolactin. It is one of the most widely used GH-optimization combinations, convenient as a single reconstituted vial.
Key Benefits
- Amplifies natural pulsatile GH release
- Two complementary mechanisms in one injection
- Supports recovery, sleep, and body composition
- Minimal impact on cortisol and prolactin
Set a goal (top of the page) to see how Ipamorelin / CJC-1295 (No DAC) scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Water retention
- Injection site reactions
- Head rush / flushing
- Tingling in extremities
Legal & Regulatory Status
Research use only. Not FDA-approved. No studies exist on this specific combination; the evidence tier reflects the individual components (ipamorelin, CJC-1295), which have only limited human GH-PK data.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
No citations available. We could not locate indexed peer-reviewed literature for this compound specifically. That absence is the reason for its evidence rating — treat any claims about it, including ours, with corresponding caution.
